VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
95 hedge funds and large institutions have $27.9M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 20 increasing their positions, 34 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
89% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 19
Holders
95
Holding in Top 10
–
Calls
$75K
Puts
$2K
Top Buyers
| 1 | +$74.8K | |
| 2 | +$38.7K | |
| 3 | +$36.2K | |
| 4 |
Renaissance Technologies
New York
|
+$34.2K |
| 5 |
Barclays
London,
United Kingdom
|
+$14.2K |
Top Sellers
| 1 | -$175K | |
| 2 | -$115K | |
| 3 | -$83.8K | |
| 4 |
HF
HRT Financial
New York
|
-$82K |
| 5 |
Jane Street
New York
|
-$74.6K |